- /
- Supported exchanges
- / US
- / PRCT.NASDAQ
Procept Biorobotics Corp (PRCT NASDAQ) stock market data APIs
Procept Biorobotics Corp Financial Data Overview
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Procept Biorobotics Corp (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Procept Biorobotics Corp data using free add-ons & libraries
Get Procept Biorobotics Corp Fundamental Data
Procept Biorobotics Corp Fundamental data includes:
- Net Revenue: 308 M
- EBITDA: -97 469 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-03
- EPS/Forecast: -0.3243
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Procept Biorobotics Corp News
New
EAU Upgrade Puts Aquablation And PROCEPT BioRobotics In Focus
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. PROCEPT BioRobotics' Aquablation therapy has been upgrade...
PROCEPT BioRobotics (PRCT) Strengthens Its Case with Expanding System Base
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is one of the best pure-play robotics stocks to buy now. PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is among the best pure-play robotics stocks to buy now. The co...
Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
SAN CARLOS, Calif., March 24, 2026 /PRNewswire/ -- Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its se...
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
PROCEPT BioRobotics Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasia SAN ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.